Chronic Obstructive Pulmonary Disease (COPD) Clinical Trial
Official title:
Effects of Pulmonary Rehabilitation on Computerized Respiratory Sounds in Patients With Chronic Obstructive Pulmonary Disease
Verified date | January 2018 |
Source | Aveiro University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The effect of pulmonary rehabilitation in patients with chronic obstructive pulmonary disease
(COPD) has been based on systemic outcome measures, however, little is known about the
effectiveness of this intervention on patients' lung function. The forced expiratory volume
in one second (FEV1), despite of being the gold standard for assessing lung function in COPD,
is poorly responsive to pulmonary rehabilitation. Thus, an objective and responsive outcome
measure to assess the effect of pulmonary rehabilitation on lung function is needed.
Computerized respiratory sounds have been found to be a more sensitive indicator, detecting
and characterizing the severity of respiratory diseases before any other measure, however its
potential to detect changes after pulmonary rehabilitation has never been explored.
Therefore, this study aims to assess the effects of pulmonary rehabilitation on the
characteristics of computerized respiratory sounds in patients with COPD.
A randomized controlled study with one group undergoing pulmonary rehabilitation (n=25) and
other group receiving standard care (n=25) will be conducted. The pulmonary rehabilitation
program will included exercise training (3*week) and psychoeducation (1*week).
Computerized respiratory sounds, lung function, exercise capacity, quadriceps muscle
strength, health-related quality of life and health services use will be assessed in both
groups, at baseline, immediately post-intervention and at follow-ups (3 and 6 months after
PR).
Descriptive and inferential statistics will be used.
It is expected that significant changes occur on the characteristics of computerized
respiratory sounds in patients enrolled in the pulmonary rehabilitation group, in comparison
with patients receiving standard care. Thus, computerized respiratory sounds could provide a
simple, objective and non-invasive measure to assess lung function changes after pulmonary
rehabilitation.
Status | Completed |
Enrollment | 106 |
Est. completion date | September 30, 2013 |
Est. primary completion date | March 20, 2013 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - clinical diagnosis of COPD according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) criteria; - = 18 years old; - clinical stability for 1 month prior to the study (no hospital admissions, exacerbations or changes in medication); - able to provide their own informed consent. Exclusion Criteria: - presence of concomitant respiratory diseases; - presence of severe psychiatric conditions; - presence of severe neurologic/ musculoskeletal conditions and/or unstable cardiovascular disease. |
Country | Name | City | State |
---|---|---|---|
Portugal | University of Aveiro | Aveiro |
Lead Sponsor | Collaborator |
---|---|
Aveiro University | Fundação para a Ciência e a Tecnologia |
Portugal,
Jácome C, Marques A. Pulmonary rehabilitation for mild COPD: a systematic review. Respir Care. 2014 Apr;59(4):588-94. doi: 10.4187/respcare.02742. Epub 2013 Oct 8. Review. — View Citation
Marques A, Oliveira A, Jácome C. Computerized adventitious respiratory sounds as outcome measures for respiratory therapy: a systematic review. Respir Care. 2014 May;59(5):765-76. doi: 10.4187/respcare.02765. Epub 2013 Sep 17. Review. Erratum in: Respir Care. 2016 Jan;61(1):e1. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in respiratory sounds | Computerized respiratory sounds will be recorded with modified stethoscopes at seven chest locations: trachea; posterior right and left; anterior right and left and lateral right and left, as recommended by the Computerized Respiratory Sound Analysis (CORSA) guidelines. | 1 week prior intervention; 1, 12 and 24 weeks post intervention | |
Secondary | Change in lung function | Lung function will be assessed with a spirometric test, following the American Thoracic Society/European Respiratory Society guidelines. | 1 week prior intervention; 1, 12 and 24 weeks post intervention | |
Secondary | Change in exercise capacity | Exercise capacity will be assessed with the 6-minute walk test, following the American Thoracic Society guidelines. | 1 week prior intervention; 1, 12 and 24 weeks post intervention | |
Secondary | Change in quadriceps muscle strength | Quadriceps isotonic muscle strength will be assessed with the 1 repetition maximum (1-RM), following the American College of Sports Medicine guidelines. | 1 week prior intervention; 1, 12 and 24 weeks post intervention | |
Secondary | Change in health-related quality of life | The St. George's Respiratory Questionnaire (SGRQ) is a disease-specific instrument designed to measure quality of life in patients with chronic lung disease. It has 3 domains: symptoms, activities and impact. Scores range from 0 to 100 and higher values indicate poorer quality of life. | 1 week prior intervention; 1, 12 and 24 weeks post intervention | |
Secondary | Change in health services use | number of visits to casualty; number and duration of hospital admissions. | 1 week prior intervention; 1, 12 and 24 weeks post intervention |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03282019 -
Study of Long-term HFNC for COPD Patients With HOT
|
N/A | |
Completed |
NCT05573464 -
A Study to Assess the Safety of Budesonide/Glycopyrronium/Formoterol Fumarate With the Hydrofluoroolefin Propellant in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
|
Phase 3 | |
Recruiting |
NCT06040086 -
Efficacy and Safety of Tozorakimab in Symptomatic Chronic Obstructive Pulmonary Disease With a History of Exacerbations
|
Phase 3 | |
Not yet recruiting |
NCT06376994 -
Multi-Center Clean Air Randomized Controlled Trial in COPD
|
Phase 3 | |
Completed |
NCT02797392 -
Feasibility of a Preventive Program Against Lifestyle Related Diseases
|
N/A | |
Completed |
NCT02728674 -
Management of Patients With Respiratory Symptoms in Sweden
|
N/A | |
Completed |
NCT02926534 -
Cross-Sectional Study of COPD Prevalence Among Smokers, Ex-smokers and Never-Smokers in Almaty, Kazakhstan
|
N/A | |
Recruiting |
NCT02415478 -
Bronchioscopic Lung Volume Reduction (BLVR)
|
N/A | |
Completed |
NCT03487406 -
Anti-platelet Therapy in the Prevention of Cardiovascular Disease in Patients With COPD (APPLE-COPD: ICON 2)
|
Phase 2 | |
Completed |
NCT02518139 -
A 52-Week Parallel Group Safety Study of TD-4208 in Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 3 | |
Completed |
NCT02512510 -
Efficacy Study of Nebulized TD-4208 for Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 3 | |
Completed |
NCT02459080 -
Efficacy Study of Nebulized TD-4208 for Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 3 | |
Completed |
NCT02774226 -
Long Term Nitric Oxide Bioavailability on Vascular Health in Chronic Obstructive Pulmonary Disease
|
Phase 2 | |
Withdrawn |
NCT01908933 -
Study of the AeriSeal System Treatment in Patients With Advanced Non-Upper Lobe Predominant Heterogeneous Emphysema
|
Phase 3 | |
Completed |
NCT01908140 -
Study of Aclidinium Bromide/Formoterol Fumarate Compared With Salmeterol/Fluticasone Propionate in Patients With Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 3 | |
Completed |
NCT01615484 -
Ex-vivo Perfusion and Ventilation of Lungs Recovered From Non-Heart-Beating Donors to Assess Transplant Suitability
|
N/A | |
Completed |
NCT01893476 -
A Pragmatic Cluster Trial of a Tailored Intervention to Improve COPD Management
|
N/A | |
Completed |
NCT01701869 -
Microbiology & Immunology of the Chronically-inflamed Airway
|
N/A | |
Recruiting |
NCT02527486 -
Seoul National University Airway Registry
|
N/A | |
Terminated |
NCT01388920 -
Efficacy and Safety Study of Tesamorelin in Chronic Obstructive Pulmonary Disease (COPD) Subjects With Muscle Wasting
|
Phase 2 |